Journal of Clinical Laboratory Analysis · 2016 · 15 citations · 31 references
MedicineNephrologyDialysisHemodialysisRenal Replacement TherapyChronic Kidney DiseaseRenal DiseaseRenal Function TestsRenal ImpairmentCardiovascular Risk In HemodialysisCardiovascular Risk MarkersCardiovascular Risk StratificationChronic Renal InsufficiencyOsteoprotegerin Dysregulation
BACKGROUND: To evaluate osteoprotegerin (OPG) levels in relation to cardiovascular (CV) risk factors in patients with chronic kidney disease (CKD) on different regimens of renal replacement therapy. METHODS: A total of 143 patients with CKD and 30 healthy controls were included in this study and divided into five categories, including predialysis patients with chronic renal failure (preD; n = 36), chronic peritoneal dialysis patients (PD; n = 36), hemodialysis patients (HD; n = 35), renal transplant patients (RT; n = 36), and controls (n = 30). Data on demographics, concomitant diseases and CV risk factors, serum OPG levels, and correlates of serum OPG levels were determined. RESULTS: Serum OPG (pmol/l) levels were significantly higher in HD (P <0.001 for each), PD (P <0.001 for each), and preD (P <0.01 vs. control, P <0.05 vs. RT) groups than RT and control groups. Diabetics than nondiabetics in HD (P = 0.008), PD (P = 0.024), and RT (P = 0.004) groups and males than females in PD group (P = 0.021) had higher OPG levels. Serum OPG levels were associated positively with age in HD (P <0.001), PD (P = 0.001), and in overall population (P <0.001). CONCLUSION: Our findings revealed increased serum levels of OPG in dialysis and preD patients compared to RT and controls. In the patient groups receiving two dialysis treatment, the levels were worse, indicating a more pronounced vascular injury. Age, C-reactive protein (CRP), high-density lipoprotein cholesterol (HDL-C), and cystatin C (CysC) in CKD patients, CRP and PTH in the control subjects, and age and BMI in the overall population were the significant correlates of serum OPG levels.
31
Warren S. Browner, Li‐Yung Lui, Steven R. Cummings · The Journal of Clinical Endocrinology & Metabolism · 2001 · 511 citations · Full text
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
Stefan Kiechl, Georg Schett, Gregor K. Wenning et al. · Circulation · 2004 · 507 citations · Full text
Shuichi Jono, Yuji Ikari, Atsushi Shioi et al. · Circulation · 2002 · 490 citations · Full text